Single Dose Pharmacokinetics of Kapanol™, a New Oral Sustained-Release Morphine Formulation
- 1 May 1994
- journal article
- Published by Springer Nature in Clinical Drug Investigation
- Vol. 7 (5) , 262-274
- https://doi.org/10.1007/bf03257418
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Morphine-6-glucuronide, a potent mu agonistPublished by Elsevier ,2002
- Morphine Pharmacokinetics and Metabolism in HumansClinical Pharmacokinetics, 1993
- High-performance liquid chromatographic determination of morphine and its 3- and 6-glucuronide metabolites: improvements to the method and application to stability studiesJournal of Chromatography B: Biomedical Sciences and Applications, 1991
- Sensitive and specific radioimmunoassays for opiates using commercially available materials. I: Methods for the determinations of morphine and hydromorphoneJournal of Pharmaceutical Sciences, 1991
- Plasma concentrations and renal clearances of morphine-6- and morphine-3-glucuronide in cancer patients receiving morphinePain, 1990
- ANALGESIC ACTIVITY OF MORPHINE-6-GLUCURONIDEThe Lancet, 1988
- Morphine-6-glucuronide: Analgesic effects and receptor binding profile in ratsLife Sciences, 1988
- Morphine‐6‐glucuronide Has High Affinity for the Opioid ReceptorBasic & Clinical Pharmacology & Toxicology, 1987
- Steady-State Pharmacokinetics of Controlled Release Oral Morphine Sulphate in Healthy SubjectsClinical Pharmacokinetics, 1986
- Morphine metabolism in cancer patients on increasing oral doses‐no evidence for autoinduction or dose‐dependence.British Journal of Clinical Pharmacology, 1983